Drug intelligence / Profile preview

NGE-UD

Development stage: Unknown
Administration: Ophthalmic

Overview

NGE-UD, also known as Next Generation Emulsion Preservative Free Eye Drops, is an over-the-counter (OTC) ophthalmic product indicated for the temporary relief of symptoms of eye dryness. It is designed for adult patients experiencing dry eye symptoms, particularly those who are high digital device users. The formulation is preservative-free and delivered as an emulsion to help stabilize the tear film and provide ocular surface lubrication in cases of Dry Eye Disease (DED). The drug does not contain active pharmaceutical ingredients with a specific molecular target but acts by supplementing and stabilizing the tear film to relieve dryness[1].

Brand names: NGE-UDNext Generation Emulsion Preservative Free Eye Drops
Other names: Next Generation Emulsion Preservative Free Eye Drops

Beyond the preview

Go deeper on NGE-UD.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on NGE-UD.

Explore the full profile